NNOX
Get informed when a big investor buys or sells
+ FollowOvervalued by 1637.1% based on the discounted cash flow analysis.
| Market cap | $29.27 Million |
|---|---|
| Enterprise Value | $6.58 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.26 |
| Outstanding Shares | 69,931,000 |
| P/E Ratio | -0.22 |
|---|---|
| PEG | -0.08 |
| Price to Sales | - |
| Price to Book Ratio | 0.34 |
| Enterprise Value to Revenue | 0.42 |
| Enterprise Value to EBIT | -0.07 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.27 |
| Debt to Equity | 0.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 109.66% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 13.89% |
|---|---|
| Total Invested | $31▼ 100.00% |
| Investors Holding | 1▼ 108.00% |
No data
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.